To further understand the role of the urinary CXCL10 found in bladder cancer patients treated with BCG, the activation and migration of the immune effector cells cultured in the presence of the chemokine were evaluated in vitro. The gene discussed is CXCL10; the disease is urinary bladder carcinoma.